CN Patent

CN114174282A — 作为甲状腺素受体-β激动剂的哒嗪酮类衍生物及其应用

Assigned to Medshine Discovery Inc · Expires 2022-03-11 · 4y expired

What this patent protects

作为甲状腺素受体‑β激动剂的哒嗪酮类衍生物，及其在制备甲状腺素受体‑β激动剂相关疾病的药物中的应用。具体公开了式(I)所示化合物或其药学上可接受的盐。

USPTO Abstract

作为甲状腺素受体‑β激动剂的哒嗪酮类衍生物，及其在制备甲状腺素受体‑β激动剂相关疾病的药物中的应用。具体公开了式(I)所示化合物或其药学上可接受的盐。

Drugs covered by this patent

Patent Metadata

Patent number
CN114174282A
Jurisdiction
CN
Classification
—
Expires
2022-03-11
Drug substance claim
No
Drug product claim
No
Assignee
Medshine Discovery Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.